Literature DB >> 10192589

The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder.

M L Crismon1, M Trivedi, T A Pigott, A J Rush, R M Hirschfeld, D A Kahn, C DeBattista, J C Nelson, A A Nierenberg, H A Sackeim, M E Thase.   

Abstract

BACKGROUND: This article describes the development of consensus medication algorithms for the treatment of patients with major depressive disorder in the Texas public mental health system. To the best of our knowledge, the Texas Medication Algorithm Project (TMAP) is the first attempt to develop and prospectively evaluate consensus-based medication algorithms for the treatment of individuals with severe and persistent mental illnesses. The goals of the algorithm project are to increase the consistency of appropriate treatment of major depressive disorder and to improve clinical outcomes of patients with the disorder.
METHOD: A consensus conference composed of academic clinicians and researchers, practicing clinicians, administrators, consumers, and families was convened to develop evidence-based consensus algorithms for the pharmacotherapy of major depressive disorder in the Texas mental health system. After a series of presentations and panel discussions, the consensus panel met and drafted the algorithms.
RESULTS: The panel consensually agreed on algorithms developed for both nonpsychotic and psychotic depression. The algorithms consist of systematic strategies to define appropriate treatment interventions and tactics to assure optimal implementation of the strategies. Subsequent to the consensus process, the algorithms were further modified and expanded iteratively to facilitate implementation on a local basis.
CONCLUSION: These algorithms serve as the initial foundation for the development and implementation of medication treatment algorithms for patients treated in public mental health systems. Specific issues related to adaptation, implementation, feasibility testing, and evaluation of outcomes with the pharmacotherapeutic algorithms will be described in future articles.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10192589

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  48 in total

1.  Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorder.

Authors:  Gordon Parker; Max Fink; Edward Shorter; Michael Alan Taylor; Hagop Akiskal; German Berrios; Tom Bolwig; Walter A Brown; Bernard Carroll; David Healy; Donald F Klein; Athanasios Koukopoulos; Robert Michels; Joel Paris; Robert T Rubin; Robert Spitzer; Conrad Swartz
Journal:  Am J Psychiatry       Date:  2010-07       Impact factor: 18.112

2.  Lessons learned in implementing evidence-based practices: implications for psychiatric administrators.

Authors:  Richard M Bloch; Sy Atezaz Saeed; Jeanne C Rivard; Christina Rausch
Journal:  Psychiatr Q       Date:  2006

Review 3.  The promise and reality of pharmacogenetics in psychiatry.

Authors:  Peter P Zandi; Jennifer T Judy
Journal:  Psychiatr Clin North Am       Date:  2010-03

4.  Letter to the Editor concerning "the prevalence of depressive symptoms before and after surgery and its association with disability in patients undergoing lumbar spinal fusion" by M. Wahlman et al. (2014) Eur Spine J 23:129-134.

Authors:  Hakan Sarman; Ugur Cakir; Bunyamin Koc; Ismail Boyraz; Cengiz Isik
Journal:  Eur Spine J       Date:  2014-12-09       Impact factor: 3.134

5.  The Validity and Sensitivity of PANSS-6 in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Study.

Authors:  Søren D Østergaard; Leslie Foldager; Ole Mors; Per Bech; Christoph U Correll
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

Review 6.  Treating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV clinicians.

Authors:  Julie L Adams; Bradley N Gaynes; Teena McGuinness; Riddhi Modi; James Willig; Brian W Pence
Journal:  AIDS Patient Care STDS       Date:  2012-11       Impact factor: 5.078

7.  Translating Science Into Service: Lessons Learned From the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study.

Authors:  Norman Sussman
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

8.  What Are the Implications of the STAR*D Trial for Primary Care? A Review and Synthesis.

Authors:  Nhu N Huynh; Roger S McIntyre
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

9.  Cognitive behavioral analysis system of psychotherapy and brief supportive psychotherapy for augmentation of antidepressant nonresponse in chronic depression: the REVAMP Trial.

Authors:  James H Kocsis; Alan J Gelenberg; Barbara O Rothbaum; Daniel N Klein; Madhukar H Trivedi; Rachel Manber; Martin B Keller; Andrew C Leon; Steven R Wisniewski; Bruce A Arnow; John C Markowitz; Michael E Thase
Journal:  Arch Gen Psychiatry       Date:  2009-11

10.  Insufficient depression treatment in outpatient settings.

Authors:  Frank Schneider; Sandra Kratz; Isaac Bermejo; Ralph Menke; Christoph Mulert; Ulrich Hegerl; Mathias Berger; Wolfgang Gaebel; Martin Härter
Journal:  Ger Med Sci       Date:  2004-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.